On November 13, 2026, the Board, at its regular meeting held after the Annual Meeting of Share Owners of the Company, appointed Rebecca S. Sidelinger as a new independent director, effective immediately. Ms. Sidelinger is the former President, Reliability Solutions at Flex Ltd. (Nasdaq: FLEX), a global provider of design, manufacturing, and supply chain solutions, where she served from 2022 to 2024. In that role, she led Flex's Reliability Solutions segment, which includes its Automotive, Health Solutions, and Industrial business units, and was responsible for the segment's strategy, growth, and design-led customer engagements. From 2011 to 2022, Ms. Sidelinger held leadership roles at Honeywell International Inc. (Nasdaq: HON), the last four of which was on the Honeywell Aerospace leadership team as President of Mechanical Systems & Components, a $3 billion business unit that included Honeywell's Air & Thermal Systems, Mechanical Systems, and Honeywell Federal Solutions businesses. She previously spent 25 years in leadership positions with GE Transportation Systems and GE Motors. Ms.
|
Kimball Electronics, Inc. is a contract manufacturer providing electronics manufacturing services (EMS) and contract development and manufacturing organization (CDMO) solutions. The company produces durable electronics, printed circuit board assemblies, and high-level final assemblies for automotive, medical, and industrial applications. Its CDMO offerings include medical disposables, drug delivery devices, precision molded plastics, clean room assembly, and sterilization management. Kimball Electronics operates facilities in the United States, China, India, Mexico, The Netherlands, Poland, Romania, and Thailand. The company was founded in 1961 and incorporated in 1998. It is in the process of rebranding to Kimball Solutions, Inc. to reflect its expanded portfolio of non-electronic manufacturing solutions. The company acquired Helvoet Polymer Technologies B.V. in July 2026 to enhance its capabilities in precision molded plastics and medical device component manufacturing. Summarised from the company's own disclosures, fiscal year ended Aug 2026 |
Industry Electronics & Computer Distribution | Homepage kimballelectronics.com |
| Sector Technology | IR page investors.kimballelectronics.com/overview/default.aspx | |
|
Tags
electronics manufacturing services, contract development and manufacturing organization, medical devices, drug delivery systems, precision molded plastics, automotive electronics, industrial automation, clean room assembly, printed circuit board assemblies, sterilization management, Kimball Solutions, Helvoet Polymer Technologies B.V.
|
Press page kimballelectronics.com/news |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 655.264M |
| Market cap (USD) | $ 655.264M |
| P/E | 32.54 |
| PEG | — |
| P/BV | 1.13 |
| P/S | 0.45 |
| P/OCF | 14.60 |
| P/FCF | -128.96 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 4.8% |
| ROI | 4.0% |
| ROIC | 4.9% |
| Profit margin | 2.0% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -20.6% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | 40.4% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 20 |
| Quality score | -5.9% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.431B | 1.487B | 1.715B | 1.823B | 1.35B | 1.292B | 1.201B | 1.182B | 1.072B | 930.914M | 842.06M | 819.35M | 741.53M |
| Net profit | 27.96M | 16.984M | 20.511M | 55.831M | 31.253M | 56.791M | 18.196M | 31.558M | 16.752M | 34.179M | 22.287M | 26.205M | 24.613M |
| Free cash flow | 20.779M | 150.661M | 27.143M | -103.171M | -157.135M | 91.713M | 34.444M | -31.413M | 14.324M | 13.5M | 3.168M | -4.978M | 18.902M |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (USD) | 170M | 174M | 226M | 180M | 203M | 223M | 308M | 282M | 223M | 219M |
| ↳ YoY growth | +13.5% | +2.2% | +30.0% | -20.1% | +12.9% | +9.6% | +38.3% | -8.4% | -21.1% | -1.7% |
| ↳ 5y CAGR | +11.9% | +5.2% | +6.3% | +5.6% | +12.2% | +4.6% | +4.3% | +1.5% | ||
| Borrowings, current (USD) | — | — | — | — | — | — | — | 59.8M | 17.4M | 8.2M |
| Borrowings, non-current (USD) | — | — | — | — | — | — | — | 235M | 130M | 108M |
| Lease liabilities (USD) | — | — | — | 2.03M | 1.6M | 3.1M | 2.6M | 1.77M | 11.9M | 16.9M |
| Cash and deposits (USD) | 44.6M | 46.4M | 49.3M | 65M | 106M | 49.9M | 43M | 78M | 88.8M | 88.9M |
| Intangible assets (USD) | 4.58M | 4.38M | 22.2M | 19.3M | 17M | 14.7M | 12.3M | 2.99M | 2.43M | 1.92M |
| Right-of-use assets (USD) | — | — | — | 2.03M | 1.6M | 3.1M | 2.6M | 1.77M | 11.8M | 10.9M |
| Net debt (borrowings + leases - cash) (USD) | — | — | — | — | — | — | — | 217M | 70.2M | 44.1M |
| Cash flow detail | ||||||||||
| Operating cash flow (USD) | 46.8M | 40.2M | -6.75M | 72.8M | 130M | -83.2M | -13.8M | 73.2M | 184M | 72.3M |
| Purchases of property, plant and equipment (USD) | -33.3M | -25.9M | -24.7M | -38.4M | -38.4M | -74M | -89.4M | -46.1M | -33.3M | -51.5M |
| Purchases of intangible assets (USD) | -1.02M | -643,000 | -1.18M | -385,000 | -970,000 | -757,000 | -1.32M | -966,000 | -399,000 | -187,000 |
| Change in receivables (cash effect) (USD) | -19.3M | -2.88M | -36.5M | 41.9M | -28.4M | -26.5M | -82.4M | 8.49M | 71.8M | -6.03M |
| Change in inventories (cash effect) (USD) | -8.55M | -55.8M | -35.1M | -15.1M | 18.6M | -203M | -50.2M | 64.2M | 74.6M | -19.9M |
| Change in payables (cash effect) (USD) | 9.49M | 33.3M | 8M | 3.62M | 14.6M | 96.8M | 20.4M | -103M | -2.79M | 20M |
| Share buybacks (cash effect) (USD) | -22.3M | -9.55M | -23.4M | -8.79M | -3M | -8.95M | 0.00 | -2.85M | -12M | -11.9M |
| Interest paid (cash effect) (USD) | -294,000 | -410,000 | -3M | -4.9M | -2.5M | -2.33M | -15.3M | -19.4M | -18.1M | -9.04M |
| Income taxes paid (cash effect) (USD) | -5.9M | -14.7M | -10.2M | -9.1M | -13.4M | -14.3M | -13.7M | -27.3M | -12.8M | -14.2M |
| Share-based compensation (USD) | 3.48M | 5.3M | 5.68M | 4.04M | 3.91M | 6.22M | 6.91M | 7.19M | 6.52M | 8.23M |
| Operating cash flow before change in receivables (USD) | 66M | 43.1M | 29.8M | 30.9M | 158M | -56.7M | 68.6M | 64.7M | 112M | 78.3M |
| Free cash flow (OCF - PPE - intangibles) (USD) | 12.5M | 13.7M | -32.6M | 34.1M | 90.7M | -158M | -104M | 26.2M | 150M | 20.6M |
| Income detail | ||||||||||
| Research and development expense (USD) | 10M | 11M | 15M | 17M | 21M | 23.7M | 24.4M | 18.3M | 17.5M | 19.1M |
| ↳ 5y CAGR | +6.6% | +13.4% | +13.6% | +18.5% | +18.8% | +17.3% | +4.1% | +0.6% | -1.9% | |
| Total comprehensive income (USD) | 37.3M | 18.9M | 30.8M | 15.3M | 62.5M | 16.5M | 64.5M | 13.8M | 35.9M | 22.2M |
| Comprehensive income to owners (USD) | 37.3M | 18.9M | 30.8M | 15.3M | 62.5M | 16.5M | 64.5M | 13.8M | 35.9M | 22.2M |
| Provision for credit losses (USD) | — | — | — | — | — | — | — | 2M | — | 400,000 |
| Credit cost ratio (credit losses / average receivables) (%) | — | — | — | — | — | — | — | 0.7% | — | 0.2% |
| Reported | Aug 29, 2017 | Aug 28, 2018 | Aug 27, 2019 | Aug 27, 2020 | Aug 27, 2021 | Aug 30, 2022 | Aug 24, 2023 | Aug 22, 2025 | Nov 6, 2025 | Nov 5, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR. Press releases from the company's own website, newest first.
November 4, 2026
First Quarter 2027 Highlights
- Net sales of $390.8 million, a 5% increase sequentially and up 7% compared to Q1 fiscal 2026
- Year-over-year organic sales growth of 3%, driven by increases in all verticals
- Medical sales increased 14% with 9% organic growth
- Operating income of $12.4 million, or 3.2% of net sales; adjusted operating income margin of 4.3% of net sales
- Cash Conversion Days of 82, equaling the multiyear low from last quarter
- Debt totaling $235.7 million, cash of $72.8 million, and borrowing capacity of $198.0 million
- Invested $3.1 million to repurchase 127,000 shares of common stock
- Company reiterates guidance for fiscal 2027 with sales expected at the high end of the range, driven by continued strength in the Medical vertical
JASPER, Ind.,--(BUSINESS WIRE)-- Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the first quarter ended September 30, 2026.
| Three Months Ended | |||||||
| September 30, | |||||||
| (Amounts in Thousands, except EPS) | 2026 | 2025 | |||||
| Net Sales | $ | 390,803 | $ | 365,603 | |||
| Operating Income | $ | 12,374 | $ | 14,454 | |||
| Adjusted Operating Income (non-GAAP) | $ | 16,990 | $ | 17,534 | |||
| Operating Income % | 3.2 | % | 4.0 | % | |||
| Adjusted Operating Income (non-GAAP) % | 4.3 | % | 4.8 | % | |||
| Net Income | $ | 2,642 | $ | 10,086 | |||
| Adjusted Net Income (non-GAAP) | $ | 6,121 | $ | 12,250 | |||
| Diluted EPS | $ | 0.11 | $ | 0.40 | |||
| Adjusted Diluted EPS (non-GAAP) | $ | 0.25 | $ | 0.49 |
Commenting on today’s announcement, Richard D. Phillips, Chief Executive Officer, stated, “I’m encouraged by our first quarter results and solid start to fiscal 2027. Sales increased both sequentially and year-over-year, margins were healthy, and cash conversion days were once again at a multiyear low. The top line benefited from organic sales growth and the contribution from Helvoet Polymer Technologies, our recent tuck-in acquisition in the medical CDMO. The organic growth was in line with expectations and driven by a high single-digit increase in Medical. This growth aligns with our strategic focus to balance the portfolio across the verticals.”
Mr. Phillips continued, “Our excitement for the overall fit and growth opportunities of Helvoet are higher now than ever. With the backdrop of a strong balance sheet, we’re investing in medical growth by integrating Helvoet, ramping operations in Indianapolis, leveraging our capabilities as a full service provider, and unlocking synergies across our global footprint. Fiscal 2027 marks an important milestone in our journey and we are reiterating our guidance for the year with sales expected at the high end of the range, driven by continued strength in Medical.”
Net Sales by Vertical Market for Q1 Fiscal 2027
| Three Months Ended | |||||||||||||||
| September 30, | |||||||||||||||
| (Amounts in Millions) | 2026 | * | 2025 | * | PercentChange | ||||||||||
| Automotive | $ | 170.5 | 44 | % | $ | 164.4 | 45 | % | 4 | % | |||||
| Medical | 115.7 | 29 | % | 101.6 | 28 | % | 14 | % | |||||||
| Industrial | 104.6 | 27 | % | 99.6 | 27 | % | 5 | % | |||||||
| Total Net Sales | $ | 390.8 | 100 | % | $ | 365.6 | 100 | % | 7 | % | |||||
| * As a percent of Total Net Sales | |||||||||||||||
| – Automotive includes chassis control - steering, chassis control - braking, and body controls | |||||||||||||||
| – Medical includes sleep & oxygen therapy, defibrillation (AEDs), surgical systems, in vitro diagnostics, imaging systems, drug delivery/auto-injectors, patient monitoring, and microfluidics | |||||||||||||||
| – Industrial includes climate controls, off-highway/commercial equipment, IoT & factory automation, energy, and public safety |
FISCAL YEAR 2027 GUIDANCE
As part of today’s announcement, the Company reiterated its guidance for fiscal 2027 with net sales expected at the high end of the range of $1,535 - $1,560 million, adjusted operating income of 4.4% - 4.7% of net sales, and capital expenditures of $50 - $60 million.
| Conference Call / Webcast |
| Date: Thursday, November 5, 2026Time: 10:00 AM Eastern TimeLive Webcast: investors.kimballelectronics.com/events-and-presentations/eventsDial-in #: 888-396-8049 (or 416-764-8646)For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com. |
Forward-Looking Statements
Certain statements contained within this release are considered forward-looking, including our guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “expect,” “should,” “goal,” “predict,” “will,” “future,” “optimistic,” “confident,” and “believe.” Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as war, global health emergencies, availability or cost of raw materials and components, tariffs and other trade barriers, foreign exchange rate fluctuations, and our ability to convert new business opportunities into customers and revenue. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the company are contained in its Annual Report on Form 10-K for the year ended June 30, 2026.
Non-GAAP Financial Measures
This press release contains non-GAAP financial measures. The non-GAAP financial measures contained herein include organic sales growth, adjusted selling and administrative expenses, adjusted operating income, adjusted EBITDA, adjusted net income, and adjusted diluted EPS. Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the Reconciliation of Non-GAAP Financial Measures section below. Management believes these measures are useful and allow investors to meaningfully trend, analyze, and benchmark the performance of the company’s core operations. The company’s non-GAAP financial measures are not necessarily comparable to non-GAAP information used by other companies.
About Kimball Electronics/Kimball Solutions
Kimball Electronics is a global, multifaceted manufacturer offering Electronics Manufacturing Services (EMS) and Contract Development and Manufacturing Organization (CDMO) solutions to customers around the world. From our operations in the United States, China, India, Mexico, The Netherlands, Poland, Romania, and Thailand, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.
To learn more about Kimball Electronics, visit www.kimballelectronics.com .
Lasting relationships. Global success.
| Condensed Consolidated Statements of Income | |||||||||||||
| (Unaudited) | Three Months Ended | ||||||||||||
| (Amounts in Thousands, except Per Share Data) | September 30, 2026 | September 30, 2025 | |||||||||||
| Net Sales | $ | 390,803 | 100.0 | % | $ | 365,603 | 100.0 | % | |||||
| Cost of Sales | 359,929 | 92.1 | % | 336,767 | 92.1 | % | |||||||
| Gross Profit | 30,874 | 7.9 | % | 28,836 | 7.9 | % | |||||||
| Selling and Administrative Expenses | 18,055 | 4.6 | % | 13,090 | 3.5 | % | |||||||
| Restructuring Expense | 445 | 0.1 | % | 1,416 | 0.4 | % | |||||||
| Gain on Disposal | — | — | % | (124 | ) | — | % | ||||||
| Operating Income | 12,374 | 3.2 | % | 14,454 | 4.0 | % | |||||||
| Interest Income | 549 | 0.1 | % | 139 | — | % | |||||||
| Interest Expense | (3,519 | ) | (0.9 | )% | (2,353 | ) | (0.6 | )% | |||||
| Non-Operating Income (Expense), net | (1,601 | ) | (0.4 | )% | (1,241 | ) | (0.4 | )% | |||||
| Other Income (Expense), net | (4,571 | ) | (1.2 | )% | (3,455 | ) | (1.0 | )% | |||||
| Income Before Taxes on Income | 7,803 | 2.0 | % | 10,999 | 3.0 | % | |||||||
| Provision (Benefit) for Income Taxes | 5,161 | 1.3 | % | 913 | 0.2 | % | |||||||
| Net Income | $ | 2,642 | 0.7 | % | $ | 10,086 | 2.8 | % | |||||
| Earnings Per Share of Common Stock: | |||||||||||||
| Basic | $ | 0.11 | $ | 0.41 | |||||||||
| Diluted | $ | 0.11 | $ | 0.40 | |||||||||
| Average Number of Shares Outstanding: | |||||||||||||
| Basic | 24,330 | 24,600 | |||||||||||
| Diluted | 24,581 | 24,909 |
| Condensed Consolidated Statements of Cash Flows | Three Months Ended | ||||||
| (Unaudited) | September 30, | ||||||
| (Amounts in Thousands) | 2026 | 2025 | |||||
| Net Cash Flow provided by (used for) Operating Activities | $ | (19,324 | ) | $ | 8,065 | ||
| Net Cash Flow used for Investing Activities | (109,728 | ) | (6,202 | ) | |||
| Net Cash Flow provided by (used for) Financing Activities | 114,026 | (13,966 | ) | ||||
| Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash | (64 | ) | 116 | ||||
| Net Decrease in Cash, Cash Equivalents, and Restricted Cash | (15,090 | ) | (11,987 | ) | |||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 89,641 | 89,467 | |||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $ | 74,551 | $ | 77,480 |
| (Unaudited) | |||||||
| Condensed Consolidated Balance Sheets | September 30, 2026 | June 30, 2026 | |||||
| (Amounts in Thousands) | |||||||
| ASSETS | |||||||
| Cash and cash equivalents | $ | 72,763 | $ | 88,925 | |||
| Receivables, net | 236,068 | 218,840 | |||||
| Contract assets | 83,003 | 70,497 | |||||
| Inventories | 312,137 | 271,906 | |||||
| Prepaid expenses and other current assets | 49,371 | 42,836 | |||||
| Property and Equipment, net | 304,480 | 274,192 | |||||
| Goodwill | 50,459 | 6,191 | |||||
| Other Intangible Assets, net | 25,491 | 1,921 | |||||
| Other Assets, net | 103,426 | 116,762 | |||||
| Total Assets | $ | 1,237,198 | $ | 1,092,070 | |||
| LIABILITIES AND SHARE OWNERS’ EQUITY | |||||||
| Current portion of long-term debt | $ | 39,700 | $ | 8,202 | |||
| Accounts payable | 260,560 | 234,361 | |||||
| Advances from customers | 36,607 | 30,672 | |||||
| Accrued expenses | 58,725 | 58,860 | |||||
| Long-term debt, less current portion | 195,650 | 108,000 | |||||
| Other long-term liabilities | 63,739 | 66,843 | |||||
| Share Owners’ Equity | 582,217 | 585,132 | |||||
| Total Liabilities and Share Owners’ Equity | $ | 1,237,198 | $ | 1,092,070 |
| Other Financial Metrics | |||||||||||
| (Unaudited) | |||||||||||
| (Amounts in Millions, except CCD) | |||||||||||
| At or For the | |||||||||||
| Three Months Ended | |||||||||||
| September 30, | June 30, | September 30, | |||||||||
| 2026 | 2026 | 2025 | |||||||||
| Cash Conversion Days (CCD)(1) | 82 | 82 | 83 | ||||||||
| Open Orders(2) | $ | 690 | $ | 643 | $ | 593 |
| (1) | Cash Conversion Days (“CCD”) are calculated as the sum of Days Sales Outstanding plus Contract Asset Days plus Production Days Supply on Hand less Accounts Payable Days and less Advances from Customers Days. CCD, or a similar metric, is used in our industry and by our management to measure the efficiency of managing working capital. | |
| (2) | Open Orders are the aggregate sales price of production pursuant to unfulfilled customer orders. |
| Select Financial Results of Helvoet | |||
| (Unaudited) | |||
| (Amounts in Millions) | |||
| Three Months | |||
| Ended | |||
| September 30, | |||
| 2026 | |||
| Net Sales | $ | 12.4 |
| Reconciliation of Non-GAAP Financial Measures | |||||||
| (Unaudited, Amounts in Thousands, except Per Share Data) | |||||||
| Three Months Ended | |||||||
| September 30, | |||||||
| 2026 | 2025 | ||||||
| Net Sales Growth (vs. same period in prior year) | 7 | % | (2 | )% | |||
| Acquisition Impact | 3 | % | — | % | |||
| Foreign Currency Exchange Impact | 1 | % | 1 | % | |||
| Organic Sales Growth | 3 | % | (3 | )% | |||
| Net Sales Growth (vs. same period in prior year), Medical Vertical | 14 | % | 13 | % | |||
| Acquisition Impact, Medical Vertical | 5 | % | — | % | |||
| Foreign Currency Exchange Impact, Medical Vertical | — | % | 1 | % | |||
| Organic Sales Growth, Medical Vertical | 9 | % | 12 | % | |||
| Selling and Administrative Expenses, as reported | $ | 18,055 | $ | 13,090 | |||
| Stock Compensation Expense | (1,677 | ) | (1,563 | ) | |||
| SERP | 14 | (225 | ) | ||||
| Acquisition Amortization | (532 | ) | — | ||||
| Acquisition Costs | (1,976 | ) | — | ||||
| Adjusted Selling and Administrative Expenses | $ | 13,884 | $ | 11,302 | |||
| Operating Income, as reported | $ | 12,374 | $ | 14,454 | |||
| Stock Compensation Expense | 1,677 | 1,563 | |||||
| SERP | (14 | ) | 225 | ||||
| Restructuring Expense | 445 | 1,416 | |||||
| Asset Impairment (Gain on Disposal) | — | (124 | ) | ||||
| Acquisition Amortization | 532 | — | |||||
| Acquisition Costs | 1,976 | — | |||||
| Adjusted Operating Income | $ | 16,990 | $ | 17,534 | |||
| Adjusted Operating Income | $ | 16,990 | $ | 17,534 | |||
| Depreciation & Amortization Excluding Acquisition Amortization | 10,571 | 9,117 | |||||
| Adjusted EBITDA | $ | 27,561 | $ | 26,651 | |||
| Net Income, as reported | $ | 2,642 | $ | 10,086 | |||
| Stock Compensation Expense, After-Tax | 1,272 | 1,185 | |||||
| Restructuring Expense, After-Tax | 312 | 1,073 | |||||
| Asset Impairment (Gain on Disposal), After-Tax | — | (94 | ) | ||||
| Acquisition Amortization, After-Tax | 396 | — | |||||
| Acquisition Costs, After-Tax | 1,499 | — | |||||
| Adjusted Net Income | $ | 6,121 | $ | 12,250 | |||
| Diluted Earnings per Share, as reported | $ | 0.11 | $ | 0.40 | |||
| Stock Compensation Expense | 0.05 | 0.05 | |||||
| Restructuring Expense | 0.01 | 0.04 | |||||
| Acquisition Amortization | 0.02 | — | |||||
| Acquisition Costs | 0.06 | — | |||||
| Adjusted Diluted Earnings per Share | $ | 0.25 | $ | 0.49 | |||
Andrew D. Regrut
Vice President, Investor Relations, Strategic Development, and Treasurer
812.827.4151
[email protected]
Source: Kimball Electronics, Inc.
Primary IR Contact
Andy Regrut
VP, Investor Relations, Strategic Development, and Treasurer
Email Alerts
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At Kimball Electronics Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Kimball Electronics Inc. to send you the requested Investor Email Alert updates.
* Required
Email Address *
Investor Alert OptionsInvestor Alert Options *
| News |
| Events & Presentations |
| Quarterly Reports |
| Annual Reports |
| SEC Filings |
| End of Day Stock Quote |
Submit Submit
Email Alert Sign Up Confirmation
-
About Us
-
industries
-
capabilities
-
Insights
-
Sustainability
-
facilities
-
Careers
-
helpful links
-
© 2026 | Privacy Policy | Human rights & supply chain transparency
Follow us on |
October 21, 2026
JASPER, Ind.--(BUSINESS WIRE)-- Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report first quarter fiscal year 2027 financial results on Wednesday, November 4, 2026, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, November 5, 2026, at 10:00 a.m. Eastern Time.
- The telephone number to access the conference call is 888-396-8049 / +1 416-764-8646.
- A live webcast of the conference call can be accessed at investors.kimballelectronics.com . For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com .
About Kimball Electronics/Kimball Solutions
Kimball Electronics is a global, multifaceted manufacturer offering Electronics Manufacturing Services (EMS) and Contract Development and Manufacturing Organization (CDMO) solutions to customers around the world. From our operations in the United States, China, India, Mexico, The Netherlands, Poland, Romania, and Thailand, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.
To learn more about Kimball Electronics, visit www.kimballelectronics.com .
Lasting relationships. Global success.
Andrew D. Regrut
Vice President, Investor Relations, Strategic Development, and Treasurer
812.827.4151
[email protected]
Source: Kimball Electronics, Inc.
Primary IR Contact
Andy Regrut
VP, Investor Relations, Strategic Development, and Treasurer
Email Alerts
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At Kimball Electronics Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Kimball Electronics Inc. to send you the requested Investor Email Alert updates.
* Required
Email Address *
Investor Alert OptionsInvestor Alert Options *
| News |
| Events & Presentations |
| Quarterly Reports |
| Annual Reports |
| SEC Filings |
| End of Day Stock Quote |
Submit Submit
Email Alert Sign Up Confirmation
-
About Us
-
industries
-
capabilities
-
Insights
-
Sustainability
-
facilities
-
Careers
-
helpful links
-
© 2026 | Privacy Policy | Human rights & supply chain transparency
Follow us on |
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Kimball Electronics, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| SQLV | 0.33% | 3,668 | $ 93.901K | Jun 30, 2026 |
| ESSC | 0.27% | 3,900 | $ 96.447K | Jul 31, 2026 |
| SYZ | 0.25% | 6,644 | $ 170.086K | Jun 30, 2026 |
| OASC | 0.23% | 9,084 | $ 214.564K | Aug 31, 2026 |
| GGTL | 0.14% | 737 | $ 18.867K | Jun 30, 2026 |
| SEIS | 0.11% | 25,368 | $ 649.421K | Jun 30, 2026 |
| BSVO | 0.11% | 142,810 | $ 2.61M | Nov 18, 2026 |
| AVUV | 0.08% | 1,396,240 | $ 26.333M | Nov 16, 2026 |
| PSC | 0.05% | 49,338 | $ 1.263M | Jun 30, 2026 |
| DFSV | 0.04% | 558,731 | $ 11.23M | Nov 12, 2026 |
| AVSC | 0.03% | 52,779 | $ 995.412K | Nov 16, 2026 |
| DFAT | 0.02% | 360,822 | $ 7.253M | Nov 12, 2026 |
| IVSS | 0.02% | 186 | $ 4,761.60 | Jun 30, 2026 |
| FESM | 0.01% | 31,462 | $ 805.427K | Jun 30, 2026 |
| DFAS | 0.01% | 185,045 | $ 3.719M | Nov 12, 2026 |
| DXUV | 0.00% | 14,217 | $ 285.762K | Nov 12, 2026 |
| MSSM | 0.00% | 788 | $ 18.613K | Aug 31, 2026 |
| DFUV | 0.00% | 19,417 | $ 390.282K | Nov 12, 2026 |
| DFAC | 0.00% | 99,530 | $ 2.001M | Nov 12, 2026 |
| DFSU | 0.00% | 2,500 | $ 50.25K | Nov 12, 2026 |
| DCOR | 0.00% | 34,763 | $ 698.736K | Nov 12, 2026 |
| EBI | 0.00% | 375 | $ 8,857.50 | Aug 31, 2026 |
| DFAU | 0.00% | 5,324 | $ 107.012K | Nov 12, 2026 |
| DFUS | 0.00% | 7,104 | $ 142.79K | Nov 12, 2026 |
| AVUS | 0.00% | 21,921 | $ 413.43K | Nov 16, 2026 |
| AVSU | 0.00% | 545 | $ 10.279K | Nov 16, 2026 |
.png?sfvrsn=4d077ba6_1)